BioNTech SE ADR Rises Friday, Outperforms Market

Dow Jones2022-08-20

DJ BioNTech SE ADR Rises Friday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

The BioNTech SE ADR (BNTX) inched 0.21% higher to $147.92 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.29% to 4,228.48 and Dow Jones Industrial Average falling 0.86% to 33,706.74. The ADR's rise snapped a three-day losing streak. BioNTech SE ADR closed $240.08 below its 52-week high ($388.00), which the company reached on August 23rd.

The ADR underperformed when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ rose 0.40% to $141.85 and Amgen Inc. $(AMGN)$ rose 0.46% to $250.86. Trading volume (919,320) remained 208,035 below its 50-day average volume of 1.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2022.

 

$(END)$ Dow Jones Newswires

August 19, 2022 16:41 ET (20:41 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment